Bio-Techne Corp. (TECH)
NASDAQ
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
72.5552 wk Range
43.20Overview - TECH - Bio-Techne Corp.
Key Statistics
Valuation
Enterprise Value
11.38B
P/E (Trailing)
62.46
P/E (Forward)
31.33
PEG Ratio
-0.14
Price / Sales (TTM)
9.35
Price / Book
5.36
EV / EBITDA
34.08
Profitability
Gross Margin
65.81%
Profit Margin
14.96%
Operating Margin
27.87%
Return on Assets
6.67%
Return on Equity
9.03%
Ownership
Shares Outstanding
156.09M
Float
156.14M
Short % of Shares Outstanding
4.71%
Held by Insiders
0.34%
Held by Institutions
114.71%
Price stats
Beta
1.29
50-Day Avg
72.33
200-Day Avg
62.41
Dividends
Payout Ratio
27.59%
Frequency
Quarterly
Analyst Consensus
13 analysts
Average price target
$ 70.73Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TECH - Bio-Techne Corp.
Peers - TECH - Bio-Techne Corp.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- TECHNASDAQBio-Techne Corp.11.37BMarket Cap+17.79%52-week change62.47P/E (Trailing)14.96%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - TECH - Bio-Techne Corp.
About
Bio-Techne Corp. is a global life sciences company that develops, manufactures, and sells reagents, analytical instruments, and precision diagnostics for research, diagnostic, and bioprocessing applications. Its portfolio supports workflows across basic research, translational science, and clinical decision-making,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
